Delivery Order SPE2DE24D0013-SPE2D626F582P
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $1,757.00 firm fixed-price delivery order to Cepheid Inc. on November 5, 2025, with an ultimate completion date of November 20, 2025. This delivery order, issued without a set-aside designation, supports the agency's molecular diagnostic supply requirements and leverages Cepheid's established expertise as a primary federal supplier of diagnostic solutions. The work will be performed at Cepheid's headquarters in Sunnyvale, California....
- The Defense Logistics Agency Medical Supply Chain issued a delivery order valued at $1,843.36 to Cepheid Inc. on December 1, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, designated as XPRSMVP-10, carries no set-aside designation and represents a small procurement under the agency's broader medical supply chain contracting framework. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of molecular diagnostic systems...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $13,825.20 firm fixed-price delivery order to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. This delivery order, issued on September 19, 2025, with an ultimate completion date of September 26, 2025, carries no set-aside designation and represents a procurement of diagnostic equipment or testing supplies. The award leverages Cepheid's expertise in advanced...
- Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California, was awarded a delivery order valued at $5,440 on December 5, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by December 12, 2025, and will be performed at the contractor's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with completion targeted for November 20, 2025, represents a procurement of diagnostic testing supplies and reagents under an existing indefinite delivery contract vehicle. The award carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $6,800 on December 8, 2025, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order (4570200478) is set to be completed by December 15, 2025, with performance occurring at Cepheid's Sunnyvale facility. The award falls under an existing Indefinite Delivery Contract (IDC) with the Department of Veterans Affairs VISN 17,...
- The U.S. Defense Logistics Agency (operating as Medical Supply Chain) awarded a delivery order valued at $4,449.60 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 22, 2025. The contract, designated as firm fixed-price with no set-aside designation, has an ultimate completion date of September 29, 2025. This delivery order represents a short-duration procurement typical of the Department of Defense's medical supply chain operations, which...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $52,387.20 to Cepheid Inc. on September 26, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order (contract number 4569624736, XPRS4PLEX-10) carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The award represents a discrete purchase under one of Cepheid's larger indefinite delivery...
- The Defense Logistics Agency (DLA), under the Medical Supply Chain program, awarded a delivery order valued at $1,648.38 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on August 12, 2025. This firm fixed-price delivery order, without set-aside designation, represents a continuation of Cepheid's ongoing provision of diagnostic testing solutions to federal defense and healthcare agencies. The contract is scheduled for ultimate completion by August 19, 2025,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F582PDelivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a $1,440 firm fixed-price delivery order to Cepheid Inc. on December 1, 2025, with an ultimate completion date of December 8, 2025. This delivery order, issued under contract number 4570137197, represents a procurement of molecular diagnostic supplies or reagents from Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic testing systems. The award carries no set-aside designation, reflecting Cepheid's competitive positioning in the federal procurement market for diagnostic solutions. The contract will be performed at Cepheid's Sunnyvale facility. This delivery order falls within Cepheid's broader relationship with the Defense Logistics Agency Medical Supply Chain, which has issued numerous delivery orders for diagnostic testing supplies, test kits, and reagents. Cepheid has established itself as a primary federal supplier of molecular diagnostic capabilities through its GeneXpert platform and associated testing solutions, serving multiple federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. The company holds substantial indefinite delivery contracts with the VA, including a $32.8 million single-award contract with VISN 6 extending through September 2030, demonstrating the federal government's reliance on Cepheid for ongoing molecular diagnostic procurement to support clinical laboratory operations and infectious disease testing requirements across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/30/25 |